Table 2:

Measurements of CVR, FA, MD, T2, and perfusion metrics in WMH and contralateral homologous NAWM

WMH (Contralateral to NAWM), Mean (SD)NAWM (Contralateral to WMH), Mean (SD)Paired Differencest-Scoredf
Mean (SD)95% CI Difference
CVR (% BOLD/mm Hg)0.05 (0.07)0.13 (0.03)0.06 (0.03)0.05–0.0714.8a74
FA (unitless)0.28 (0.07)0.50 (0.11)0.18 (0.04)1.72–1.9138.2a74
MD (×10−3mm2/s)1.37 (0.11)0.84 (0.03)0.51 (0.11)0.48–0.5440.7a74
T2 (ms)136.7 (14.4)84.9 (4.9)51.6 (11.8)48.5–54.832.3a53
CBF (mL/100 g/min)18.2 (3.5)21.0 (4.4)1.9 (4.3)0.16–3.72.8 (P = .01)24
rCBV (AU)b103.9 (10.1)117.5 (9.3)8.9 (19.7)0.8–17.72.3 (P = .03)24
MTT (s)4.6 (0.5)4.1 (0.3)0.3 (1.1)−0.1–0.81.5 (P = .15)24
Tmax (s)3.5 (0.3)2.4 (0.2)1.1 (0.8)0.8–1.26.8a24
TTP (s)22.3 (1.3)20.8 (1.0)1.6 (1.2)1.1–2.16.7a24
  • Note:—FA indicates fractional anisotropy; rCBV, relative CBV; Tmax, time-to-maximum; AU, arbitrary units.

  • a P < .001 compared with contralateral WMH.

  • b These arbitrary units indicate that WMH are reduced compared to contralateral NAWM by 10.2%